Shesa's AUGUST 2020 Investment Blog
AUGUST 2020 - INVESTMENT BLOG
By Shesa Nayak
U.S. Stock Market Update
It has been an eventful year the world has ever seen! We saw major collapses in the world economy, stock market, fastest bear market in 19 days, also we saw the fastest recoveries in the stock market. It’s hard to imagine but that’s the fact! The Q2 earnings are in full swing, 63% of S&P 500 companies have reported earning so far. Major technology companies Apple, Amazon, Microsoft, Google and Facebook have all reported their earnings. The first four tech giant (AAPL, AMZN, MSFT, GOOG) commands an incredible market capitalization of $5.98 Trillion, a whopping 28% of the U.S GDP!! So, these elephants in the room are pulling the stock indexes despite a horrible state of the economy attributed by Coronavirus pandemic. There are still more than 30 million Americans looking for job and currently unemployment rate is 11.1%. But the stock market does not seem to be concerned as it keeps going up and up. Thanks to Federal Reserve’s unlimited quantitative easing program. Meanwhile, another round of stimulus discussion has been going on between democrats and republicans but it’s still in deadlock due to unemployment assistance funding. Hopefully, they should be able to negotiate and pull it through this week. Stock market going up is a good thing for all of us as an investor and we should not be too concerned. Ultimately, investment is made to get optimal return on investment! Having said that, now that the major earnings have come and we are heading to August and September, the risks increase because these are most unfriendly month for investors. So, will there be an imminent pullback or correction in the stock market? We do not know for sure but that’s what history has proven; we will see how it goes. In addition, not to forget that we are approaching to the U.S presidential election in November 3, 2020, that may have some impact on the stock market. Well, I will share my analysis but before that let’s first take a quick look to U.S. stock market indexes.
| 2020 | | | | |||
Indexes | 1/2/20 | Close FRI (7/31/20) | Change in 2020 | % Change in 2020 | All Time High | From All Time High | % from All Time High |
DOW | 28,538.44 | 26,428.00 | -2,110.44 | -7.40 | 29,568.57 | -3,140.57 | -10.62% |
S&P 500 | 3,230.78 | 3,271.12 | 40.34 | 1.25 | 3,393.52 | -122.40 | -3.61% |
NASDAQ | 8,972.60 | 10,745.27 | 1,772.67 | 19.76 | 10,221.85 | 523.42 | 5.12% |
BTK | 5,067.45 | 5,657.48 | 590.03 | 11.64 | 5936.43 | -278.95 | -4.70% |
NBI | 3,786.54 | 4,224.36 | 437.82 | 11.56 | 4413.24 | -188.88 | -4.28% |
Next Investment Meet
Thanks to all my WhatsApp group members for their overwhelming response to attend the next investment meet on Saturday, 8/8. It will be a virtual session on Zoom.
Major Economy News
Q2 2020 Earnings: As of date, 63% of the companies in the S&P 500 have reported reporting out of which 84% of S&P 500 companies have reported a positive EPS surprise and 69% have reported positive revenue surprise. One reason of such huge beat could be attributed to reduce in earnings estimates by the analysts community.
Earnings Growth: For Q2 2020, the earnings decline for the S&P 500 is -35.7% (better than projected -43.8% earnings growth). If -35.7% is the actual decline for this quarter, it will mark the largest year-over-year decline in earnings reported by the index since Q4 2008 (-69.1%).
Valuation: The forward 12-month P/E ratio for the S&P 500 is 22.0. This P/E ratio is above the 5-year average (17.0) and above the 10-year average (15.3)
- Apple announced 4-for-1 Stock split, effective to shareholders at the close of business on 8/28.
- Weekly jobless claim: 1.434 million vs. 1.45 million expected.
- Unemployment: 11.1% down from 13.3%. The total numbers are above 30 million.
- Housing starts: 1.186M, up from 1.011M last month and down from 1.235M one year ago. This is a change of 17.31% from last month and -3.97% from one year ago..
- GDP Growth Rate: -32.9% quarter over quarter -9.5% year over year.
- US Total GDP/Economy: $21.44 trillion (Top 4 tech companies constitute whopping 28% of the GDP. The size of the U.S. economy was at $20.58 trillion in 2018
- Interest Rate: 0.25%
- Inflation rate: 0.6%
- U.S Coronavirus Cases: 4.6 million, Death: 154,000 reported as of 8|2|2020
- President Trump floated the idea of delaying November's presidential election though he does not have
- power to do so.
- U.S Presidential Election: Tuesday, November 3, 2020.
Which direction Stock Market may go in the near term?
It has been an eventful year the world has ever seen! We saw major collapse in the stock market and the fastest bear market in 19 days and so also we saw the fastest recoveries in the stock market. It’s hard to imagine but that’s the fact! So, what else can we expect to see going forward? The most awaited tech companies reported their earnings last Thursday and we saw some rallies in Nasdaq. But what next? Economy continues to be crippled by COVID-19 and most importantly we are approaching two of the most turbulent months of U.S stock market i.e. August and September. The important caveat that it’s extremely difficult to predict about a year that has so far delivered an unpredictable phenomenon from virus attack => social distancing => business lockdown => market collapse => market recoveries => urban riots => bumpy road ahead => U.S Election and possibly many more unknows as we go..
Economy: We all expected the economy to rebound in the current, third quarter of the year. However, the re-emergence of increased number of COVID-19 cases across the country could potentially derail or delay the recovery. The unemployment still stands at 11.1% which is one of the highest ever though it’s better than a month/two ago. Some jobs or businesses are gone and may never return. As we know, 70% of the U.S Economy is dependent on consumer spending. If there are no jobs for 30+ million people then most of the people will be cautions of spending money and that may further drag the economy. So far, government stimulus has helped to many Americans but according to the Republicans proposal unemployment benefits will be reduced to $200 from $600 before (till July 31st). It’s still in deadlock, we will find in next few days. The home market has started recovering to some extent due to ultra-low interest rates. Probably, this is one of the best time to refinance our homes. The GDP is down -32.9% quarter over quarter and -9.5% year over year. This probably had never happened the U.S history.
Second Stimulus Check: As we are aware, in May the government came with $2.4 Trillion package for Coronavirus relief. Meanwhile, another round of stimulus program is being discussed wherein democrats have proposed for $3.4T package and republicans have proposed for $1.1 trillion package. This stimulus was supposed to come this week but still the parties have not been able to come with a consensus. This would allow individual with adjusted gross income (AGI) up to $75,000 for single filers, $112,500 for head of household and $150,000 for married filing jointly are eligible for the full $1,200 for individuals and $2,400 married filing jointly. In addition, they are eligible for an additional $500 per qualifying child. The democrats have also proposed for unemployment benefit paying out-of-work Americans $600 per week but republicans are sticking to $200 unemployment benefit resulting further delay in approving the stimulus plan.
The Stock Market hurricane season is coming
If we see last 50 years history of the stock market, August and September are two disruptive months for the stock market. If we see the metrics of S&P 500 since World War II then the average return of S&P 500 has been as follow:
Q1: 2.2%
Q2: 1.9%
Q3: 0.5%
Q4: 3.8%
Here is how DOW has performed since 1999 – 2018:
Q1: 0.24%
Q2: 1.16%
Q3: 0.22%
Q4: 4.5%
As far as monthly ROI is concerned (S&P 500 since 1950 – Apr 2017):
· Best 3 months: APR: 1.5%, NOV: 1.5%, DEC: 1.60%
· Worst Months: Jun: -0.06%, August: -0.10%, September: -0.50%.
What do we expect in the near term? Once the business started opening in May-June there were some hope that business environment and job situation will get better and economy will rebound. However, due to many reasons (political & non-political) there have been huge resurgence of Covid-19 cases and deaths. It has resulted in further business closures and state lockdowns, which doesn’t bode well for a business revival this summer. In addition, the stock market has gone up too much too fast. So, some pullback of the stock market is long overdue. If we see more closely to the stock market indexes then 4 major next stocks (Apple, Amazon, Microsoft and Google) has whooping 28% of the U.S GDP!! The current U.S economy/GDP accounts to be $21.4 trillion. That’s incredible!! The unlimited QE endured by Federal Reserve has taken the fear from traders/investors. These big four dominate the indexes and benefit from buying by index funds, ETFs, Fed’s bond buying programs and bigger financial institutions. As a matter of fact, these stocks largely control the indexes and as a result NASDAQ has gone up 34.25% in last one year. Agreed that most of these companies keep coming with great earnings, but so much of market concentration may not be good for the overall health of stock market. Because almost one third of the market indexes and economy is revolving around big 4-5 companies. Does it mean that we should be out of tech stocks or big name tech stocks? NO absolutely “NOT”. If we do, we may be losing great return to our portfolio. I have no complain because I hold shares of most of these companies, so I am glad to see my portfolio do better. Having said that, once these big financial institutions start selling these shares, it could drag down the index heavily and correspondingly whole stock market. Though, I do not see a significant correction like we saw in March but the month of August and September have never been kind to investors. Hence, some profit taking may start sooner than later and we may see some pullbacks in next few weeks. Though, nobody knows for sure, if that happens, it may bring some good buying opportunities. On the contrary, it’s a good idea to take some profit and have some cash on the sidelines to take advantage of any such opportunity in next few weeks/months.
What next after August and September?
We may see some economy revival provided the Coronavirus cases recedes and people feel comfortable spending, shopping, travelling and businesses reopens. That may not happen until we get a vaccine. Let’s not forget another key milestone “U.S presidential election on November 3, 2020”. Please mark your calendar. How will it play? Well, nothing can be predicted from now but looks like we may see some “change..”. If there will be a change, I may have to do some re-adjustment to my portfolio. But nothing to worry from now. We’re also entering to the final two months of the federal government’s fiscal year which ends on September 30. The budget deficit is expected to be over $4 trillion due to the current stimulus. Please note that it’s three times more than the previous worst during financial crisis of 2009. With more stimulus on the way it may go to $6-7 trillion, meaning about one third of U.S economy! This is what Fed chairman Jay Powell along with ex-Fed chairman (Yellen and Bernanke) said on the testimony on July 17, “Fed would further increase the already record-level federal budget deficit.” However, they did admit that “at some point, we will have to think through how to ensure the long-run sustainability of federal finances.”. I can write long stories but for now I would like to contend here ..
My Final thoughts: As we have started the worst two months of stock market, it’s better to be vigilant and determine very carefully which equity to buy and how much to buy. It’s good to take some profit and wait for the right opportunity. However, always there are opportunities to buy/sell irrespective of market situation. I have discussed about my investment framework many times but blog readers should have their own defined framework. My view is solely based on personally what I do and that may/may not necessarily fit others.
Coronavirus Vaccine Stocks
There are numerous pharma and biotech companies who are developing vaccines. In order to revive the world economy vaccine is the KEY. Without a vaccine, we may not see significant growth. Meanwhile, federal government is pumping billions of dollars into pharmaceuticals industry as companies race to find a vaccine against COVID-19. Companies that are ahead of the rest when it comes to scientific breakthroughs are predominantly those with prior research that can be put to use, such as information about other coronavirus strains like MERS and SARS. Though there are many key players in the filed like Pfizer, AstraZeneca, JnJ, Novartis, Merck, Sanofi and so on, in my view Moderna (MRNA), Inovio (INO) and Novavax (NVAX) are the front liners. Moreover, I am more optimistic about INO, though this company is treated like an infant by the press, news media and government. In my view, Inovio has great potential because it’s a DNA vaccine, which has very less side effects, better efficacy and can be stored and transported in regular temperature. Whereas, other vaccines may have more side effects and need a cold storage to keep it in the freezer cold. Furthermore, the DNA approach is superior because it offers an incredible diverse immune response when you look at the published results; INO-4800 vaccination generated antibodies neutralizing both the earlier strain of virus as well as what should be considered extremely important. Despite all the hype surrounding COVID-19 stock, I personally feel that Inovio could be a stock to watch in next few weeks/months. I may be wrong but we will know in next couple of months. Ultimately, whoever is the winner, the world needs some vaccines to bring life to normal. There will be few winners at the end, the remaining will eclipse. We will wait and watch..
Note: I have not added this to my blog portfolio because of its high volatility and risks.
A quick glance to Cannabis Industry
It seems not many people are aware of the industry and do not consume marijuana. The industry has come out with many product lines viz. drinks, gummies, chocolate, vapes, oil, lotion and so on. Of course, another important area is its use in medical space. Here's how the cannabis industry currently stacks up against other top industries in U.S. according to National Institute of Cannabis Investors:
· Craft beer - $29 billion
· Prescription pain medication - $16.1 billion
· Legal recreational and medical cannabis (2019) - $13 billion
· The NBA - $8.8 billion
· Toothpaste - $3 billion
· Hard Seltzer - $1.6 billion
So, we could see that cannabis is more popular than we could have ever imagined! This is a good sign for the economy as the country would collect about $1.9 billion in tax this year (2019). As of date, recreational cannabis is legal in 11 states for adults over the age of 21 and legal for medical use in 33 states.
As we approach November, a number of new states are planning to have some type of cannabis reform measures on their ballots. Those states include Arizona, Arkansas, Connecticut, Florida, Idaho, Mississippi, Missouri, New Jersey, New York, Nebraska, North Dakota, Ohio, Oklahoma, Rhode Island, and South Dakota.
Without a doubt, we can look forward to a big November for legal cannabis. If democrats come to power then I can expect medical marijuana to be approved and if that happen it will be HUGE for the industry. Also, it may allow the states to have their own policies for cannabis. However, I do not expect recreational marijuana to be legal in U.S at federal level for next few years!
GOLD is on the Run: Though I do not have any position in gold at this time but I will look for opportunity to have some investment in future. The main reason is, all these stimuluses across all the countries would bring inflation once the pandemic gets over and economy condition is stabilized. It may take months or may be year but we will see uptick in inflation. Gold is the best inflation hedge. Last Tuesday, Gold prices hit an all-time high of $1,917.90 an ounce, before pulling back to about $1,880.
Major Stock Market Performances in 2020
Indexes | 52 weeks (% change) | YTD % (last blog) | YTD % Change (current) |
DOW | --0.21% | -12.34% | -7.39% |
S&P 500 | 11.56% | -6.86% | -1.25% |
NASDAQ | 34.25% | 12.78% | 19.76% |
China Shanghai Index | 15.42% | -2.31% | 8.52% |
India BSE Sensex | 1.32% | -14.74% | -8.84% |
Japan Nikki | 2.95% | -4.84% | -8.23% |
Hongkong Hang Seng | -8.63% | -12.91% | -12.75% |
Source: Wall Street Journal
Sectorial Performances 1 Year % Change (U.S Stocks)
Sectors | Last Blog | 1 Yr. % Change |
IT (Best sector YTD) | 32.07% | 35.03% |
Consumer Discretionary | 9.23% | 18.68% |
Health Care | 5.77% | 15.41% |
Communication and Services | 6.66% | 12.05% |
Consumer Staples | -3.15% | 2.95% |
Utilities | -8.82% | 1.86% |
Real Estate | -8.97% | -3.29% |
Industrials | -13.07% | --8.55% |
Financials | -16.33% | -15.36% |
Energy | -40.03% | -41.48% |
Source: Fidelity.com
| Q2FY20 Earnings of my key Blog Portfolio Holdings | My View |
AMZN | Earnings: $5.28 billion or $10.30 per share vs. $1.46 expected . | It was an explosive quarter and I believe the company will continue to do well. No slowing in the horizon.. < Buy on Dip >. |
AAPL | Apple posted revenue of $59.7 billion and net quarterly profit of $11.25 billion. | Apple had a huge quarter!! The company also announced 1:4 stock split. It was a robust quarter but we have seen whether 5G will be released in October. That would be the catalyst! <HOLD/Buy on Dip>. |
Facebook (FB) | Earnings: $1.80 vs. $1.39 per share forecast ($5.18B) Revenue: $18.7 billion vs. $17.4 billion Daily active users: 1.79 billion vs. 1.7 billion | Despite all the controversies surrounding, the company keeps performing and deliver the goods! This is a long term BUY and HOLD. |
Shopify (SHOP) | Revenue: $714.3 vs. $511.4 million estimated. It almost doubled from the comparable period last year. | Another amazing quarter! This is another company which has to be kept for long term. Probably, I would say 2nd Amazon! < BUY on Dip >. |
MasterCard (MA) | Earnings of $1.36 per share vs. Estimate of $1.15 per share. This compares to earnings of $1.89 per share a year ago. | MasterCard is a company for long term holding. <HOLD/Buy on Dip> |
Netflix (NFLX) | EPS: $1.59 vs. $1.81 expected, missed earnings estimate. | I will say it was OK quarter as far as Revenue and Earnings were concerned. < HOLD> . |
Now let me discuss about my current month’s inclusion to my Blog Portfolio.
TG Therapeutics, Inc. (TGTX)
TGTX is a biopharmaceutical oncology company, engaged in developing and delivering medicines for patients with chronic lymphocytic leukemia (CLL), non-Hodgkin's Lymphoma (NHL), and multiple sclerosis (MS). It also develops, a novel anti-CD20 antibody known as Ublituximab, which is in Phase III study for the treatment of CLL and Multiple sclerosis (MS), a disease related to central nervous system.
Why do I like TGTX? In May the company reported top-line results of its Phase III trials evaluating a combination of drug treatments in patients with previously untreated and relapsed/ refractory chronic lymphocytic leukemia (CLL). The company did not publish the result but said that the drug had a “significant improvement in progression-free survival and will be stopped early for superior efficacy observed at the interim analysis. The company plans to submit regulatory submission and full data presentation targeted by year-end 2020. Currently, TGTX has 5 unique medicines under development, being studied in 40 clinical trials with 4 potential drugs approval are in the pipeline for 2020-2021 related to patients with various fatal diseases CLL, MZL, FL, and MS.
On June 17, Company submitted NDA (New Drug Application) to FDA for its investigational once-daily, oral drug for patients with previously treated marginal zone lymphoma (MZL) and follicular lymphoma (FL). Earlier, FDA had granted umbralisib breakthrough therapy designation for Marginal Zone Lymphoma (MZL) and orphan drug designation to its Follicular Lymphoma (FL). The drug pipelines can be viewed here https://www.tgtherapeutics.com/our-pipeline/overview/
TGTX is expected to submit approval for first and second-line treatment for Chronic Lymphocytic Leukemia ("CLL"), opening up a market potentially worth more than $9 billion. There is another drug “Ublituximab” - an antibody is progressing through phase 3 trials for Multiple Sclerosis whose results are expected before the end of 2020. Should it be approved, the treatment will enter a market that is expected to be worth $30 billon by 2025. The phase 3 trials known as ULTIMATE 1&2 are progressing well with results expected before the end of the year. The signs so far are promising, given that Ublituximab out-performed the biggest selling MS treatments by annualized relapse rate in its phase 2 trials, involving 48 patients. If successful, TGTX may be looking for a $1-2bn opportunity in this space, and it could be ready for commercialization in the first half of 2021. Thus, this year and 2021 could be huge for the TGTX shareholders, unless there are any major setbacks on these trials or FDA approval.
Competitors: TGTX will have intense competition from the companies like Roche/Genentech which has Rituxan that’s one of the world's best-selling CLL treatments since it was first approved over 20 years ago. Their sales are probably north of $9 billion. Roche has also developed a follow-up, Gazyva, which has outperformed Rituxan when treating CLL, although to date, its sales were not as great as expected! AbbVie and Johnson & Johnson are the other two key players in the field. However, trial results for TGTX were achieved against a combination of Gazyva and Rituxan and the UNITY CELL results for TGTX came pretty causing the trial to be stopped. The company expects to submit to FDA for approval and full data presentations by the end of this year.
Fundamentals
As I say most of the small or medium biotech companies do not have much to talk about the fundamentals, as these are not value stocks. The value of these biotech companies is determined based their drug pipelines (refer to my May blog), phases of their drugs, efficiency/efficacy of those drugs, institutional holdings, drug approvals, prescription growth, sales growth and so on. As far as institutional holdings are concerned, according to Fintel 72.2% of TGTX shares are held by institutions and another 9.9% stocks are held by insiders. This is a very good sign that institutions are showing high level of confidence and as day passes we will see more institutional accumulation.
Future Prospects
Visualizing the promising results and possible outcome the stock has almost gone up 100% in last couple of months. So, does it mean that it has become expensive and does not have much growth prospect? The answer “Absolutely NOT”. This is just the prototype of the actual fireworks which is yet to gain momentum. If things go well, we could see it happening in next few weeks/months or next year. Out of these three phase-III trials, even if one succeeds the stock price has more scope to grow. Looking to the past result, it looks very promising and if it goes as expected, this stock can easily double, triple or more in next few months or year from current price of $19.58. The stock had a 52 weeks high of $24.76, so buying at this price gives me 21% discount from its 52-weeks high. The company has a market capitalization of $2.24 billion. I have been accumulating this stock in small quantities since it was $5-6 and will continue to do so whenever there is opportunity.
Risk: As I say no stock is immune to stock market decline. Particularly, biotech stocks are more volatile. If the drug succeeds the stock could multiply the investment, but if it fails the stock could go significantly down. However, in case of TGTX, there is risk but in my view its “medium/high” risks. In the worst case scenario, it may pull down to around $12-13 level. But upside potential could be significant. Based on my investment framework, this risk can be mitigated by gradual accumulation of the stock rather than buying everything at once. There is a saying, “in biotech you should invest what you are willing to lose” because of their high risk. But there could also be significant reward with biotechs. However, I do not think TGTX has that significant risk, though nobody can tell about the future!
My Final thoughts
Oncology is having huge prospects in biotech filed now and going forward. With the billions of dollars going into new drugs, partnering, mergers and buyouts of drug companies; oncology companies are in a prime position of acquiring or being acquired. As the new drug policies from government keeps reducing the prescription drug prices, the bigger pharma/biotech companies will start looking aggressively to increase their revenue and profits. One way is, they can do their own R&D but it’s not always easy to be successful with self R&D for many reasons, hence mergers and acquisitions are key. As a matter of fact, I will not be surprised if TGTX can be acquired in the foreseeable future because of its strong pipeline of drugs. Today the news came that Siemens is acquiring Varian Medical for $16.4 billion, 24% premium from its Friday’s close. Having said that, I do not invest thinking that a company will be acquired! I invest if I like the company that fits to my research and investment framework. And TGTX fits to my framework, so I am invested and will do further as and when opportunities arise. As an investor, we should always have some exit strategy and take some profit when warranted. We can invest for long term but a small portion of the portfolio should be traded to get better return on investment in the long run. That way, one won’t be panicked even if the stock takes a beating and as a matter of fact we will view the decline as an opportunity as opposed to be panicked. Investors who can withstand some volatility and have patience for long term can expect a much better ROI investing in TGTX in the long run. I am willing to do that, hence invested in TGTX.
Shesa’s Blog Portfolio (As of August 30, 2020)
Equity | Suggested Price | Current Price | Suggested Date | % Change | My View |
STOCK (All prices are in USD) | |||||
51.63 | 425.04 | 1/25/13 | 723% | Buy on Dip after Split. | |
47 | 253.67 | 11/13/13 | 440% | Buy on Dip | |
77.18 | 308.53 | 12/12/13 | 300% | HOLD | |
311.73 | 3164.68 | 4/12/14 | 915% | Buy on Dip | |
67.28 | 251.02 | 2/21/16 | 273% | Buy on Dip | |
36.53 | 29.36 | 5/28/18 | -20% | HOLD | |
134.81 | 1024 | 11/25/18 | 660% | Buy on Dip | |
297.57 | 488.88 | 1/6/19 | 64% | HOLD | |
17.66 | 6.48 | 2/17/19 | -63% | Long Term BUY. Updated 8/30/20. | |
20.16 | 18.28 | 12/10/19 | -9% | HOLD | |
87.53 | 85.18 | 9/1/19 | -3% | HOLD | |
8.74 | 8.45 | 1/1/20 | -3% | HOLD | |
4.27 | 11.94 | 1/29/20 | 180% | Accumulate | |
12 | 13.88 | 3/22/20 | 16% | Accumulate | |
76.91 | 125.9 | 4/19/20 | 64% | BUY | |
54.59 | 62.35 | 5/25/20 | 14% | BUY | |
45.3 | 60.36 | 6/28/20 | 33% | Buy on Dip | |
19.58 | 19.58 | 8/2/20 | 0% | NEW ADDITION | |
ETF | |||||
139.1 | 204.31 | 8/16/15 | 47% | HOLD | |
MUTUAL FUND | |||||
11.46 | 22.96 | 3/1/13 | 100% | HOLD | |
59.45 | 165.64 | 12/20/14 | 179% | HOLD | |
9.05 | 20.08 | 1/15/16 | 122% | HOLD | |
37.32 | 82.73 | 3/20/16 | 122% | HOLD | |
43.66 | 68.6 | 9/24/17 | 57% | HOLD | |
Note: Dividends are not adjusted on the price. | |||||
N.A: Date Not available as yet. | | | | ||
Positions CLOSED since last Blog
None.
That’s all for today. Wish you great investing! Stay tuned for my next blog. Thanks for your time. If you want to get alert on my investment action, then please subscribe to shesagroup_invest@googlegroups.com or you can also join my WhatsApp group, if interested.
Disclaimer: This blog is meant to provide my opinion only. The information provided is to the best of my knowledge but may not be accurate. I do NOT provide any professional recommendation to buy/sell any stock, ETF, mutual fund, or any other security(s). As an investor, it’s your hard-earned money and you decide what is best for you. The above are merely my own opinions. Please contact a professional money manager to buy/sell any security. I do not charge any fees or commission by writing the blog except anything from Google AdSense. I have position(s) on whatever security I write on my blog and avoid recommending any security that I do not own or follow. Anybody buying or selling the equities mentioned here would do it on their own risk.
Note: Click on Blog archives to read all my Blogs and updates.
Please add my WhatsApp number 9439534650 in your group. Hope you are doing well.
ReplyDeleteDear sesha !
DeleteI am kshyudhasagagr Choudhury sambalpur university please recall and add in your WhatsApp group